<DOC>
	<DOCNO>NCT00532506</DOCNO>
	<brief_summary>The purpose study evaluate clinical efficacy safety SK-0403 patient Type2 Diabetes Mellitus</brief_summary>
	<brief_title>Phase II Dose-Finding Study SK-0403 With Type 2 Diabetes Mellitus</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>Treatmentnaive subject diagnose type 2 diabetes mellitus Stable diet program least 8 week Criteria HbA1c meet Type 1 diabetes Patients treat antidiabetic drug Insulin</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>74 Years</maximum_age>
	<verification_date>October 2008</verification_date>
</DOC>